LIMX
Limitless X Holdings Inc.1.4000
+0.0000+0%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
23.67MP/E (TTM)
-Basic EPS (TTM)
-1.25Dividend Yield
0%Recent Filings
8-K
Fitness lease, toxic notes flood
Limitless X Holdings subsidiary inked a 5-year lease on October 15, 2025, for 3,815 sq ft in LA to launch the Manny Pacquiao Impact Performance & Training Center, with rent kicking off February 2026 at $14,306 monthly and a $97K security deposit. Yet the company swiftly raised $565K via four high-risk convertible notes from November 3-11—$150K CFI (6% OID), $275K Labrys (9% OID + 6,750 commitment shares), $140K GS (10% OID), $110K Auctus (w/ warrants)—packing steep discounts, amortization mandates, and dilution bombs. Cash crunch screams loud.
8-K
Sanders named President
Limitless X Holdings appointed Daniel C. Sanders as President effective January 4, 2026, to oversee management, scientific innovation, product development, regulatory matters, manufacturing, and retail channels. Sanders, 33, brings expertise scaling operations—boosting capacity over 500% at Innovative Life Sciences—and securing distribution in Walmart, Target, and Costco. Initial $250,000 salary deferred 120 days for stock. New leader sharpens retail push.
10-Q
Q3 FY2025 results
Limitless X Holdings posted Q3 revenue of $248K, down 59% y/y from $607K yet holding gross margins steady at 75.9% versus 74.6%. Operating loss widened to $1.2M from $502K on elevated G&A, while net loss hit $3.1M—versus $727K last year—driven by $1.7M debt settlement losses exceeding operating shortfalls by over 20%. Debt restructuring slashed liabilities from $13.2M to $3.2M, leaving $52K cash against $189K related-party notes. Inventory climbed to $88K. Balance sheet breathes easier. Suppliers hold sway.
8-K
Preferred stock reclassification
Limitless X Holdings Inc. amended its Class C Convertible Preferred Stock designation effective September 30, 2025, stripping liquidation preferences beyond legal minimums and eliminating conversion rights tied to liquidation events. This tweak aims to reclassify the stock as permanent equity, pending auditor nod, potentially strengthening the balance sheet. Auditors will decide.
8-K
Strategic transformation and capital raise
Limitless X Holdings announced its SEC-qualified Regulation A Tier 2 offering on September 3, 2025, introducing perpetual preferred stock (LIMXP) with a 15% annual dividend to fuel growth in wellness, entertainment, and digital assets while preserving common shareholder value. The company is restructuring legacy debt, including the CEO's personal relinquishment of Series C preferred claims, to clean up its balance sheet and reduce negative equity. This positions Limitless X for expansion into AI-driven health diagnostics via BodyCor and film production through Limitless Films. Forward-looking plans target rapid revenue growth, yet risks like market acceptance loom.
IPO
Website
Employees
Sector
Industry
BDPT
Bioadaptives, Inc.
0.03+0.00
CFOO
CHINA FOODS HOLDINGS LTD
0.66+0.00
HLF
Herbalife Ltd.
14.45-0.45
IMG
CIMG Inc.
1.17-0.55
LFVN
Lifevantage Corporation
6.33-0.12
LSF
Laird Superfood, Inc.
2.07+0.05
NAII
Natural Alternatives Internatio
3.19-0.01
NATR
Nature's Sunshine Products, Inc
22.38-0.85
NXMH
NEXT MEATS HLDGS INC.
0.03+0.00
PSYCF
Psyched Wellness Ltd.
0.01-0.00